Net profit of Akums Drugs & Pharmaceuticals rose 105.00% to Rs 65.21 crore in the quarter ended September 2024 as against Rs 31.81 crore during the previous quarter ended September 2023. Sales declined 12.54% to Rs 1033.09 crore in the quarter ended September 2024 as against Rs 1181.25 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1033.091181.25 -13 OPM %11.7312.85 - PBDT122.75144.95 -15 PBT87.89114.53 -23 NP65.2131.81 105 Powered by Capital Market - Live News

Akums Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 November 2024Powered by Capital Market - Live News

Akums Drugs & Pharmaceuticals has entered into a License & Distribution Agreement with Triple Hair Inc, a company duly incorporated under the laws of New Brunswick, Canada, having its registered office at 5085 Principale-Est Av, Dieppe, New Brunswick, Canada. As per the terms of the agreement, Company has been granted the exclusive rights to further develop and market the products recently innovated by Triple Hair Inc, in the Territory of India. The Company will undertake this development and commercialization after obtaining the necessary regulatory approvals or requisite licenses in India. The agreement grants the Company exclusive right to use Triple Hair`s intellectual property rights (Patent) solely to carry out the studies and perform the services as stipulated in the agreement.Further, Company will manage the commercial strategy to promote and offer Triple Hair`s patented products to its own marketing partners and clients within the Indian market exclusively. Powered by Capital Market - Live News

Net profit of Akums Drugs & Pharmaceuticals reported to Rs 60.17 crore in the quarter ended June 2024 as against net loss of Rs 188.23 crore during the previous quarter ended June 2023. Sales rose 5.07% to Rs 1019.11 crore in the quarter ended June 2024 as against Rs 969.89 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales1019.11969.89 5 OPM %12.56-12.92 - PBDT121.54-129.33 LP PBT87.48-159.04 LP NP60.17-188.23 LP Powered by Capital Market - Live News

Akums Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 24 August 2024.Powered by Capital Market - Live News